Sarah Rowan, MD
Associate Professor, Medicine-Infectious Disease

Photo
Medical School:
  • MD, University of Oklahoma College of Medicine (2004)
Undergraduate School:
  • BS, Tulane University (LA) (2000)
Residency:
  • Yale-New Haven Medical Center Program, Internal Medicine - Pediatrics (2008)
Fellowships:
  • University of Colorado, Infectious Disease (2012)
Languages: English, Spanish
Department: Medicine-Infectious Disease

Professional Titles

  • Associate Director of HIV and Viral Hepatitis Prevention, Denver Health

Teaching

  • Associate Director, Mentored Scholarly Activity (2021)
    School of Medicine, Medicine

Publications

  • Obafemi OA, Rowan SE, Nishiyama M, Wendel KA. Mycoplasma genitalium: Key Information for the Primary Care Clinician. Med Clin North Am. 2024 Mar;108(2):297-310. PubMed PMID: 38331481
  • Loy DE, Kamis K, Kanatser R, Rowan SE. Barriers to Hepatitis C Treatment and Interest in Telemedicine-Based Care Among Clients of a Syringe Access Program. Open Forum Infect Dis. 2024 Mar;11(3):ofae088. PubMed PMID: 38464492
  • Haukoos J, Faryar K, Rowan S. Human Immunodeficiency Virus Pre-Exposure Prophylaxis: The Next Wave in Emergency Department-Based Human Immunodeficiency Virus Prevention. Ann Emerg Med. 2023 Apr;81(4):482-484. PubMed PMID: 36371247
  • Rigolon A, Németh J, Anderson-Gregson B, Miller AR, deSouza P, Montague B, Hussain C, Erlandson KM, Rowan SE. The neighborhood built environment and COVID-19 hospitalizations. PLoS One. 2023;18(6):e0286119. PubMed PMID: 37314984
  • Rowan SE, Wyles DL. Don't put off until tomorrow what you can do today: Hospital admissions as an opportunity to treat hepatitis C. Clin Infect Dis. 2023 Nov 22. [Epub ahead of print] PubMed PMID: 37991385
  • Rowan SE, Haukoos J, Kamis KF, Hopkins E, Gravitz S, Lyle C, Al-Tayyib AA, Gardner EM, Galbraith JW, Hsieh YH, Lyons MS, Rothman RE, White DAE, Morgan JR, Linas BP, Sabel AL, Wyles DL. The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis C. Trials. 2023 Jan 27;24(1):63. PubMed PMID: 36707909
  • Kamis KF, Wyles DL, Minturn MS, Scott T, McEwen D, Hurley H, Prendergast SJ, Rowan SE. Hepatitis C Testing and Linkage to Care Among Adults on Probation in a Large US City. Open Forum Infect Dis. 2022 Feb;9(2):ofab636. PubMed PMID: 35111867
  • Rowan SE, McCormick DW, Wendel KA, Scott T, Chavez-van de Hey J, Wilcox K, Stella SA, Kamis K, Burman WJ, Marx GE. Lower Prevalence of SARS-CoV-2 Infection Among People Experiencing Homelessness Tested in Outdoor Encampments Compared with Overnight Shelters - Denver, Colorado, June - July 2020. Clin Infect Dis. 2022 Jan 18. [Epub ahead of print] PubMed PMID: 35040947
  • Ferrante ND, Newcomb CW, Forde KA, Leonard CE, Torgersen J, Linas BP, Rowan SE, Wyles DL, Kostman J, Trooskin SB, Lo Re V 3rd. The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population. Open Forum Infect Dis. 2022 Sep;9(9):ofac445. PubMed PMID: 36092829
  • Kamis KF, Wyles DL, Minturn MS, Scott T, McEwen D, Hurley H, Prendergast SJ, Gunter J, Rowan SE. A retrospective, descriptive study of hepatitis C testing, prevalence, and care continuum among adults on probation. Health Justice. 2022 Aug 10;10(1):26. PubMed PMID: 35947313
  • Shepard Z, Vargas Barahona L, Montalbano G, Rowan SE, Franco-Paredes C, Madinger N. Bartonella quintana Infection in People Experiencing Homelessness in the Denver Metropolitan Area. J Infect Dis. 2022 Oct 7;226(Suppl 3):S315-S321. PubMed PMID: 35749315
  • Haukoos JS, Rowan SE, Galbraith JW, Rothman RE, Hsieh YH, Hopkins E, Houk RA, Toerper MF, Kamis KF, Morgan JR, Linas BP, Al-Tayyib AA, Gardner EM, Lyons MS, Sabel AL, White DAE, Wyles DL. The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departments. Trials. 2022 Apr 25;23(1):354. PubMed PMID: 35468807
  • Brooks KM, Castillo-Mancilla JR, Morrow M, Mawhinney S, Rowan SE, Wyles D, Blum J, Huntley R, Salah L, Tehrani A, Jimmerson LC, Roon L, Bushman LR, Anderson PL, Kiser JJ. Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol use. J Antimicrob Chemother. 2022 Apr 27;77(5):1396-1403. PubMed PMID: 35194648
  • Scott E, Rowan S, Chandler K, Fisher A, Hill B, Hill J, Marx GE, Farrell E, Wendel K, Stella SA. Lessons Learned through Implementing SARS-CoV-2 Testing and Isolation for People Experiencing Homelessness in Congregate Shelters. Prog Community Health Partnersh. 2022;16(2S):13-22. PubMed PMID: 35912653
  • Haukoos JS, White DAE, Rowan SE, Lyle C, Gravitz S, Basham K, Godoy A, Kamis K, Hopkins E, Anderson E. Development of a 2-step algorithm to identify emergency department patients for HIV pre-exposure prophylaxis. Am J Emerg Med. 2022 Jan;51:6-12. PubMed PMID: 34649008
  • Rowan SE, Patel RR, Schneider JA, Smith DK. Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention. Lancet HIV. 2021 Feb;8(2):e114-e120. PubMed PMID: 33128874
  • Haukoos JS, White DAE, Rowan SE, Lyle C, Gravitz S, Basham K, Godoy A, Kamis K, Hopkins E, Anderson E. HIV Risk and Pre-Exposure Prophylaxis Eligibility Among Emergency Department Patients. AIDS Patient Care STDS. 2021 Jun;35(6):211-219. PubMed PMID: 34097464
  • Marx GE, Biggerstaff BJ, Nawrocki CC, Totten SE, Travanty EA, Burakoff AW, Scott T, De Hey JC, Carlson JJ, Wendel KA, Harcourt JL, Tamin A, Thomas JD, Rowan SE. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 on Self-Collected Saliva or Anterior Nasal Specimens Compared With Healthcare Personnel-Collected Nasopharyngeal Specimens. Clin Infect Dis. 2021 Jul 15;73(Suppl 1):S65-S73. PubMed PMID: 33912930
  • Barbera LK, Kamis KF, Rowan SE, Davis AJ, Shehata S, Carlson JJ, Johnson SC, Erlandson KM. HIV and COVID-19: review of clinical course and outcomes. HIV Res Clin Pract. 2021 Aug;22(4):102-118. PubMed PMID: 34514963
  • Kamis KF, Barbera L, Abdo M, Rowan SE, Hussain C, Gardner EM, Johnson SC, MaWhinney S, Davis AJ, Carlson J, Kozacka KA, Erlandson KM. Risk Factors for Hospitalization in People With HIV and COVID-19. J Acquir Immune Defic Syndr. 2021 Nov 1;88(3):e22. PubMed PMID: 34334740
  • Haukoos JS, Lyons MS, Rothman RE, White DAE, Hopkins E, Bucossi M, Ruffner AH, Ancona RM, Hsieh YH, Peterson SC, Signer D, Toerper MF, Saheed M, Pfeil SK, Todorovic T, Al-Tayyib AA, Bradley-Springer L, Campbell JD, Gardner EM, Rowan SE, Sabel AL, Thrun MW. Comparison of HIV Screening Strategies in the Emergency Department: A Randomized Clinical Trial. JAMA Netw Open. 2021 Jul 1;4(7):e2117763. PubMed PMID: 34309668
  • McCormick DW, Rowan SE, Pappert R, Yockey B, Dietrich EA, Petersen JM, Hinckley AF, Marx GE. Bartonella Seroreactivity Among Persons Experiencing Homelessness During an Outbreak of Bartonella quintana in Denver, Colorado, 2020. Open Forum Infect Dis. 2021 Jun;8(6):ofab230. PubMed PMID: 34239947
  • Brooks KM, Castillo-Mancilla JR, Morrow M, MaWhinney S, Rowan SE, Wyles D, Blum J, Huntley R, Salah LM, Tehrani A, Bushman LR, Anderson PL, Kiser JJ. Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD Study. Open Forum Infect Dis. 2021 Jan;8(1):ofaa564. PubMed PMID: 33447634
  • Rowan SE, Kamis KF, Beum R, Bryan K, Gawenus L, Colon Sanchez D, Hurley H. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program. J Infect Dis. 2020 Sep 2;222(Supplement_5):S384-S391. PubMed PMID: 32877565
  • Brooks KM, Castillo-Mancilla JR, Morrow M, MaWhinney S, Blum J, Wyles DL, Rowan SE, Ibrahim ME, Zheng JH, Johnson B, Gomez J, Choi YJ, Cendali F, Haas H, Roon L, Bushman LR, Anderson PL, Kiser JJ. Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir. J Antimicrob Chemother. 2020 Nov 1;75(11):3303-3310. PubMed PMID: 32766700
  • Hawkins KL, Montague BT, Rowan SE, Beum R, McLees MP, Johnson S, Gardner EM. Boosted darunavir and dolutegravir dual therapy among a cohort of highly treatment-experienced individuals. Antivir Ther. 2019;24(7):513-519. PubMed PMID: 31538963
  • Rowan SE, Muething L, Spielmann K, Blum J, Lou Y, Vaughn S, Burman WJ. The Yield of Birth Cohort Screening for Hepatitis C in Community Health Centers. J Gen Intern Med. 2019 Oct;34(10):2003-2004. PubMed PMID: 31197736
  • Kamis KF, Marx GE, Scott KA, Gardner EM, Wendel KA, Scott ML, Montgomery AE, Rowan SE. Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care. Open Forum Infect Dis. 2019 Jul;6(7):ofz310. PubMed PMID: 31341933
  • Donnelly JA, Deem TT, Duffy MA, Watkins AK, Al-Tayyib AA, Shodell DJ, Thrun M, Rowan SE. Applying National Estimates of Adults With Indications for Pre-Exposure Prophylaxis to Populations of Men Who Have Sex With Men and People Who Inject Drugs in Colorado: Modeling Study. JMIR Public Health Surveill. 2019 Jan 16;5(1):e11113. PubMed PMID: 30664481
  • Obafemi OA, Wendel KA, Anderson TS, Scott TE, Rowan SE, Travanty EA, Rietmeijer CA. Rapid Syphilis Testing for Men Who Have Sex With Men in Outreach Settings: Evaluation of Test Performance and Impact on Time to Treatment. Sex Transm Dis. 2019 Mar;46(3):191-195. PubMed PMID: 30363029
  • 5. Hurley H, Al-Tayyib A, Rowan SE. With the Opioid Epidemic, Communities See Dramatic Increases in Infectious Diseases. Contagion® October 2019 V4.N5. Available from: https://www.contagionlive.com/publications/contagion/2019/october/with-the-opioid-epidemic-communities-see-dramatic-increases-in-infectious-diseases
  • Bhatia R, Modali L, Lowther M, Glick N, Bell M, Rowan S, Keglovitz K, Schneider J. Outcomes of Preexposure Prophylaxis Referrals From Public STI Clinics and Implications for the Preexposure Prophylaxis Continuum. Sex Transm Dis. 2018 Jan;45(1):50-55. PubMed PMID: 28876282
  • Hawkins KL, Hoffman M, Okuyama S, Rowan SE. A Case of Fulminant Meningococcemia: It Is All in the Complement. Case Rep Infect Dis. 2017;2017:6093695. PubMed PMID: 28808592
  • Rowan SE, Rogers M, Bayer J, Smith L, Gardner EM, Johnson S, Langness J. Treatment of Hepatitis C Virus in HIV-Coinfected Individuals in Real-world Clinical Settings: Results From 2 Large HIV Care Clinics. Clin Infect Dis. 2016 Oct 1;63(7):994-5. PubMed PMID: 27369322
  • Haukoos JS, Rowan SE. Screening for HIV infection. BMJ. 2016 Jan 19;532:i1. PubMed PMID: 26785991
  • Short R, Gardner E, Blum J, Vaughn S, Rowan S. Prevalence of Gonorrhea and Chlamydia Infections Among Human Immunodeficiency Virus-Infected Men by Anatomic Site and Presence or Absence of Symptoms. Open Forum Infect Dis. 2015 Dec;2(Suppl 1):119. PubMed PMID: 27909695
  • Rowan SE, Burman WJ, Johnson SC, Connick E, Reirden D, Daniloff E, Gardner EM. Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city. AIDS Patient Care STDS. 2014 Sep;28(9):475-82. PubMed PMID: 25084559
  • Rowan SE, Levi ME, Youngwerth JM, Brauer B, Everson GT, Johnson SC. The variable presentations and broadening geographic distribution of hepatic fascioliasis. Clin Gastroenterol Hepatol. 2012 Jun;10(6):598-602. PubMed PMID: 22373727
View All (38 Total) View Less

Professional Memberships

  • Infectious Diseases Society of America, member
  • HIVMA, member

Practice Locations

Denver Health
777 Bannock St
Denver, CO 80204
303-436-6000

Hospital Affiliation
  • Denver Health Medical Center

Specialty Information

Specialties
  • Infectious Disease, Board Certification
  • Internal Medicine, Board Certification
Clinical Interests
HIV, Hepatitis C, COVID-19, infections affecting people experiencing homelessness and people who use drugs

Personal Interests
I'm passionate about care for underserved communities. My mission is to improve the lives of people living with HIV and hepatitis C, and prevent transmission of these viruses.

Public Speaking
Yes

General Information

Medical Schools:
  • MD, University of Oklahoma College of Medicine (2004)
Undergraduate Schools:
  • BS, Tulane University (LA) (2000)
Residency Programs:
  • Yale-New Haven Medical Center Program, Internal Medicine - Pediatrics (2008)
Fellowships:
  • University of Colorado, Infectious Disease (2012)
Languages: English, Spanish
Department: Medicine-Infectious Disease
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;